Benefit with enfortumab vedotin confirmed
Crossref DOI link: https://doi.org/10.1038/s41571-021-00493-1
Published Online: 2021-03-01
Published Print: 2021-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2021-03-01
Version of Record valid from 2021-03-01
Article History
First Online: 1 March 2021